Literature DB >> 30652612

Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology.

Kent W Mouw1, Tyler F Beck1, Judith C Keen1, Adam P Dicker1.   

Abstract

PURPOSE: To assess radiation oncologists' perceptions of training and research opportunities in the fields of genomics, bioinformatics, and immunology.
MATERIALS AND METHODS: A 13-item electronic survey was sent to 101 radiation oncology department chairs and administrators. A separate 30-item electronic survey was sent to 132 members of the American Society for Radiation Oncology Science Council as well as to 565 members of the Association of Residents in Radiation Oncology. Survey responses were collected, and results were analyzed using descriptive statistics.
RESULTS: Twenty-six department chairs and 91 general respondents submitted responses. Among general respondents, 69% were current trainees and 31% had completed training. The majority of respondents (92%) were affiliated with an academic/university main campus. Approximately half of respondents (43% to 53%) reported no prior formal training in bioinformatics, genomics, or immunology. More than half of department chairs (54% to 58%) and general respondents (57% to 63%) thought that current training opportunities in these areas were absolutely or moderately insufficient. A majority of respondents (53% to 65%) thought that additional training in these areas would provide opportunity for career advancement, and 80% could identify a current or future research project that additional training in these fields would allow them to pursue. More than half of respondents expressed interest in attending a formal training course, and the majority of department chairs (22 of 26 [85%]) reported that they would probably or definitely send trainees or faculty members to a formal training course.
CONCLUSION: Among radiation oncologists surveyed, there is a perceived lack of current training opportunities in bioinformatics, genomics, and immunology. A majority of respondents reported an interest in obtaining additional training in these areas and believed that training would provide opportunity for career advancement.

Entities:  

Mesh:

Year:  2018        PMID: 30652612      PMCID: PMC6874041          DOI: 10.1200/CCI.18.00045

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  7 in total

Review 1.  Inhibitors of the PD-1 Pathway in Tumor Therapy.

Authors:  Martin W LaFleur; Yuki Muroyama; Charles G Drake; Arlene H Sharpe
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Introduction to Big Data in Radiation Oncology: Exploring Opportunities for Research, Quality Assessment, and Clinical Care.

Authors:  Stanley H Benedict; Issam El Naqa; Eric E Klein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-01       Impact factor: 7.038

Review 3.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

4.  Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takashi Yokoi; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Catherine Wadsworth; Giovanni Melillo; Haiyi Jiang; Yifan Huang; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2017-09-08       Impact factor: 91.245

5.  Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.

Authors:  William A Hall; Carmen Bergom; Reid F Thompson; Andrew M Baschnagel; Srinivasan Vijayakumar; Henning Willers; X Allen Li; Christopher J Schultz; George D Wilson; Catharine M L West; Jacek Capala; C Norman Coleman; Javier F Torres-Roca; Joanne Weidhaas; Felix Y Feng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-09       Impact factor: 7.038

6.  Delivering on the promise of precision cancer medicine.

Authors:  Michael F Berger; Eliezer M Van Allen
Journal:  Genome Med       Date:  2016-10-25       Impact factor: 11.117

7.  Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.

Authors:  Ariel E Marciscano; Joshua M Walker; Heather M McGee; Michelle M Kim; Charles A Kunos; Arta M Monjazeb; Stephen L Shiao; Phuoc T Tran; Mansoor M Ahmed
Journal:  J Immunother Cancer       Date:  2018-01-29       Impact factor: 13.751

  7 in total
  5 in total

1.  Provider Engagement in Radiation Oncology Data Science: Workshop Report.

Authors:  Anshu K Jain; Sanjay Aneja; Clifton D Fuller; Adam P Dicker; Caroline Chung; Erika Kim; Justin S Kirby; Harry Quon; Clara J K Lam; William C Louv; Chris Ahern; Ying Xiao; Todd R McNutt; Nadine Housri; Ronald D Ennis; John Kang; Ying Tang; Howard Higley; Michelle A Berny-Lang; Kevin A Camphausen
Journal:  JCO Clin Cancer Inform       Date:  2020-08

2.  Career Enrichment Opportunities at the Scientific Frontier in Radiation Oncology.

Authors:  Reid F Thompson; Clifton D Fuller; Abigail T Berman; Sanjay Aneja; Charles R Thomas
Journal:  JCO Clin Cancer Inform       Date:  2019-02

3.  Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial.

Authors:  Olivier Mir; Marie Ferrua; Aude Fourcade; Delphine Mathivon; Adeline Duflot-Boukobza; Sarah Dumont; Eric Baudin; Suzette Delaloge; David Malka; Laurence Albiges; Patricia Pautier; Caroline Robert; David Planchard; Stéphane de Botton; Florian Scotté; François Lemare; May Abbas; Marilène Guillet; Vanessa Puglisi; Mario Di Palma; Etienne Minvielle
Journal:  Nat Med       Date:  2022-04-25       Impact factor: 87.241

4.  In Regard to Wallner et al.

Authors:  John Kang; Reid F Thompson; Clifton D Fuller; Kevin A Camphausen; Peter E Gabriel; Charles R Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-01       Impact factor: 7.038

5.  National Cancer Institute Workshop on Artificial Intelligence in Radiation Oncology: Training the Next Generation.

Authors:  John Kang; Reid F Thompson; Sanjay Aneja; Constance Lehman; Andrew Trister; James Zou; Ceferino Obcemea; Issam El Naqa
Journal:  Pract Radiat Oncol       Date:  2020-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.